Diadema Partners »

Corbus Pharmaceuticals Hldgs shares owned by Diadema Partners

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.2M 555k 9.39

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
OrbiMed Advisors
Standard Life Aberdeen
Vanguard Group
Citadel Advisors
Vanguard Capital Management
Prosight Management
Diadema Partners
Susquehanna International
Stonepine Capital Management
ADAR1 Capital Management
Armistice Capital
Renaissance Technologies
BlackRock
Exome Asset Management

View all funds holding Corbus Pharmaceuticals Hldgs